Valuation: FDC Limited

Market Cap 61.49B 658M 600M 555M 502M 942M 986M 6.71B 2.66B 33.22B 2.47B 2.42B 105B P/E 2025
24.1x
P/E 2026 18.6x
Enterprise Value 56.42B 604M 550M 510M 461M 865M 905M 6.16B 2.44B 30.49B 2.27B 2.22B 96.58B EV / Sales 2025
2.8x
EV / Sales 2026 2.18x
Free-Float
30.06%
Yield 2025
1.27%
Yield 2026 1.56%
1 day-0.21%
1 week-3.29%
Current month+0.27%
1 month+9.86%
3 months+9.59%
6 months+4.12%
Current year-10.78%
1 week 368.3
Extreme 368.3
380.9
1 month 330.5
Extreme 330.5
396.95
Current year 314.75
Extreme 314.75
442
1 year 314.75
Extreme 314.75
442
3 years 314.75
Extreme 314.75
659
5 years 229.15
Extreme 229.15
659
10 years 148.2
Extreme 148.2
659
Manager TitleAgeSince
Chief Executive Officer 90 19/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 24/10/2025
Director TitleAgeSince
Director/Board Member 48 01/01/2002
Director/Board Member 63 30/09/1993
Chairman 90 01/04/2026
Change 5-day change 1-year change 3-year change Capi.($)
-0.21%-3.29%-8.01%-2.23% 660M
+0.42%-6.09%+29.94%+126.85% 1,204B
+1.46%-5.12%+33.51%+80.86% 643B
+1.75%-2.26%+25.68%+108.49% 501B
-0.60%-1.95%+27.26%+67.32% 378B
+1.79%-8.51%+42.34%+31.66% 327B
+0.41%-4.70%+27.23%+51.59% 285B
+0.81%-4.08%-1.74%+32.71% 270B
+0.80%-5.47%+30.99%+65.90% 237B
+1.41%+0.53%+35.19%+122.33% 207B
Average +0.76%-4.27%+24.24%+68.55% 405B
Weighted average by Cap. +0.81%-4.71%+28.75%+88.65%

Financials

2025 2026
Net sales 21.08B 226M 206M 190M 172M 323M 338M 2.3B 913M 11.39B 847M 829M 36.09B 21.71B 232M 212M 196M 177M 333M 348M 2.37B 940M 11.73B 872M 854M 37.16B
Net income 2.67B 28.57M 26.03M 24.09M 21.79M 40.88M 42.79M 291M 116M 1.44B 107M 105M 4.57B 2.81B 30.13M 27.45M 25.41M 22.99M 43.12M 45.14M 307M 122M 1.52B 113M 111M 4.82B
Net Debt -5.15B -55.14M -50.24M -46.5M -42.06M -78.91M -82.59M -562M -223M -2.78B -207M -203M -8.81B -5.06B -54.18M -49.37M -45.7M -41.34M -77.54M -81.16M -552M -219M -2.73B -203M -199M -8.66B
Projected Income Statement - Annual - FDC Limited
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
7,076
Date Price Change Volume
20/11/26 ₹377.65 -0.21% 4,870
19/11/26 ₹378.45 +1.22% 3,442
18/11/26 ₹373.90 -0.78% 4,019
17/11/26 ₹376.85 -0.50% 7,483
16/11/26 ₹378.75 +1.84% 7,670
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B